Home › USFDA Tracker › Sun Pharmaceutical Industries

Sun Pharmaceutical Industries — USFDA Status

Inspections, Form 483 observations, OAI classifications, warning letters, import alerts and approvals for Sun Pharmaceutical Industries (NSE: SUNPHARMA, BSE: 524715), from US FDA records and exchange filings.

37
Compliance score (5 years) · how
10
USFDA-inspected plants on record
3
OAI classifications (5y)
2
Form 483s on record (5y)
0
Open warning letters
Latest USFDA record: USFDA inspection classified NAI — 11 Sep 2026 (Ahmednagar plant). Source: FDA Data Dashboard.
USFDA events by year
2009
2014
2022
2023
2024
2025
2026
NAIVAIForm 483OAIWarning letterImport alertUS approval

Plants

PlantFEILatest resultLast inspectionHistory (newest first)
Ahmednagar
Sun Pharmaceutical Industries Limited
3003227153 NAI 11 Sep 2026
Gurugram
Sun Pharmaceutical Industries Limited
3002871444 NAI 31 Jul 2026
Vadodara
Sun Pharmaceutical Industries Ltd
3004520113 NAI 24 Jul 2026
Kanchipuram
Sun Pharmaceutical Industries Limited- Madhuranthagam
3007627683 NAI 18 Jul 2025
Halol
Sun Pharmaceutical Industries Ltd.
3002809586 OAI 13 Jun 2025
Panoli
Sun Pharmaceutical Industries Ltd.
3003952717 NAI 13 Jun 2025
Bharuch
Sun Pharmaceutical Industries Ltd
3010027135 VAI 17 May 2024
Halol
Sun Pharmaceutical Medicare Limited
3002957541 NAI 27 Feb 2024
New Delhi
Sun Pharmaceutical Industries Limited
3003892973 VAI 17 Mar 2023
Mohali
Sun Pharmaceutical Industries Limited
3002807979 OAI 12 Aug 2022

Full USFDA timeline

11 Sep 2026
NAI — clean
USFDA inspection classified NAI
Ahmednagar · FEI 3003227153 · Sun Pharmaceutical Industries Limited, Ahmednagar — Drug Quality Assurance (Drugs)
31 Jul 2026
NAI — clean
USFDA inspection classified NAI
Gurugram · FEI 3002871444 · Sun Pharmaceutical Industries Limited, Gurugram — Bioresearch Monitoring (Drugs)
24 Jul 2026
NAI — clean
USFDA inspection classified NAI
Vadodara · FEI 3004520113 · Sun Pharmaceutical Industries Ltd, Vadodara — Bioresearch Monitoring (Drugs)
28 Apr 2026
US approval
USFDA approval: DOXEPIN HYDROCHLORIDE
ANDA213919 — DOXEPIN HYDROCHLORIDE
06 Feb 2026
VAI — minor issues
USFDA inspection classified VAI
Vadodara · FEI 3004520113 · Sun Pharmaceutical Industries Ltd, Vadodara — Drug Quality Assurance (Drugs)
18 Jul 2025
NAI — clean
USFDA inspection classified NAI
Kanchipuram · FEI 3007627683 · Sun Pharmaceutical Industries Limited- Madhuranthagam, Kanchipuram — Drug Quality Assurance (Drugs)
13 Jun 2025
NAI — clean
USFDA inspection classified NAI
Panoli · FEI 3003952717 · Sun Pharmaceutical Industries Ltd., Panoli — Drug Quality Assurance (Drugs)
13 Jun 2025
OAI — serious issues
USFDA inspection classified OAI
Halol · FEI 3002809586 · Sun Pharmaceutical Industries Ltd., Halol — Drug Quality Assurance (Drugs)
02 May 2025
US approval
USFDA approval: HALOBETASOL PROPIONATE AND TAZAROTENE
ANDA217190 — HALOBETASOL PROPIONATE, TAZAROTENE
12 Jun 2024
US approval
USFDA approval: ACYCLOVIR
ANDA205470 — ACYCLOVIR
17 May 2024
VAI — minor issues
USFDA inspection classified VAI
Bharuch · FEI 3010027135 · Sun Pharmaceutical Industries Ltd, Bharuch — Drug Quality Assurance (Drugs)
27 Feb 2024
NAI — clean
USFDA inspection classified NAI
Halol · FEI 3002957541 · Sun Pharmaceutical Medicare Limited, Halol — Drug Quality Assurance (Drugs)
07 Dec 2023
US approval
USFDA approval: LIDOCAINE HYDROCHLORIDE
ANDA218182 — LIDOCAINE HYDROCHLORIDE
13 Jul 2023
VAI — minor issues
USFDA inspection classified VAI
Halol · FEI 3002957541 · Sun Pharmaceutical Medicare Limited, Halol — Drug Quality Assurance (Drugs)
17 Mar 2023
VAI — minor issues
USFDA inspection classified VAI
New Delhi · FEI 3003892973 · Sun Pharmaceutical Industries Limited, New Delhi — Bioresearch Monitoring (Drugs)
17 Feb 2023
NAI — clean
USFDA inspection classified NAI
Kanchipuram · FEI 3007627683 · Sun Pharmaceutical Industries Limited- Madhuranthagam, Kanchipuram — Drug Quality Assurance (Drugs)
07 Dec 2022
Import alert
Added to FDA import alert 66-40
Sun Pharmaceutical Industries Ltd., Halol - Baroda Highway, Halol, Gujarat INDIA
12 Aug 2022
Form 483
Form 483: 3 observations
Mohali · FEI 3002807979 · Approval and review of procedures; Complete Test Data; Written Procedures Not Followed
12 Aug 2022
OAI — serious issues
USFDA inspection classified OAI
Mohali · FEI 3002807979 · Sun Pharmaceutical Industries Limited, Mohali — Drug Quality Assurance (Drugs)
09 May 2022
Form 483
Form 483: 5 observations
Halol · FEI 3002809586 · Aseptic Processing Area; Cleaning / Sanitizing / Maintenance; Equipment Design, Size and Location; Scientifically sound laboratory controls; Written program not followed
09 May 2022
OAI — serious issues
USFDA inspection classified OAI
Halol · FEI 3002809586 · Sun Pharmaceutical Industries Ltd., Halol — Drug Quality Assurance (Drugs)
12 Mar 2014
Import alert
Added to FDA import alert 66-40
Sun Pharmaceutical Industries Limited - Karkhadi, A Plot No 817, Village Karkhadi, Padra, Gujarat INDIA
10 Sep 2009
Import alert
Added to FDA import alert 66-40
Sun Pharmaceutical Industries (prev. Ranbaxy), 3 Industrial Area, Dewas, Madhya Pradesh INDIA
10 Sep 2009
Import alert
Added to FDA import alert 66-40
Sun Pharmaceutical Industries (prev. Ranbaxy), Village Ganguwala, Tehsil-Paonta Sahib, Sirmaur, Himachal Pradesh INDIA
📎 Cite this data: Source: PharmaRoz analysis of FDA inspection data and exchange filings, updated 12 Nov 2026 — https://pharmaroz.com/company/sun-pharma